Good morning :)
$
₹
Elevance Health Inc

Elevance Health Inc

ELV

NYSE
Asset Logo

Elevance Health Inc

ELV

NYSE
$410.940.80% (-3.31)
$
₹
$410.940.80% (-3.31)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Healthcare Plans

Large Cap

With a market cap of $89.5B the stock is ranked 189

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

18.45
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.01
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$22.36
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.38
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

2.46%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

1.64%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 22 analysts' reports

Buy
18 analysts
Hold
4 analysts
Sell
0 analyst

Analysts expect a +8.64% price upside over the next year

Current Price$410.94
Target Price$450.04

Company Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Peers

Peers

UnitedHealth Group Incorporated
UNH
UnitedHealth Group Incorporated
P/E Ratio
24.14
24.14
1Y Return
12.56%
12.56%
Buy Reco %
74.07
74.07
Humana Inc
HUM
Humana Inc
P/E Ratio
37.46
37.46
1Y Return
45.68%
45.68%
Buy Reco %
34.61
34.61
Centene Corp
CNC
Centene Corp
P/E Ratio
—
—
1Y Return
108.57%
108.57%
Buy Reco %
52.63
52.63
Molina Healthcare Inc
MOH
Molina Healthcare Inc
P/E Ratio
1263.87
1263.87
1Y Return
11.73%
11.73%
Buy Reco %
43.75
43.75
HealthEquity Inc
HQY
HealthEquity Inc
P/E Ratio
34.90
34.90
1Y Return
1.12%
1.12%
Buy Reco %
92.85
92.85

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareHealthcare Plans

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Elevance Health Inc 18.452.011.38
UnitedHealth Group Incorporated24.143.421.04
Humana Inc37.462.471.32

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

50.7
1.1
49.7
0.5
50.1
1.7
50.4
1.4
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue42.5743.6445.1445.4448.8949.7750.7149.7450.1850.47
Net Income2.242.31.010.412.181.741.180.541.761.46
Net Profit Margin5.27%5.26%2.25%0.91%4.46%3.50%2.34%1.09%3.51%2.89%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. Elevance Health Inc (ELV) share price today is $410.94 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $414.46 and a day low of $406.60.

  2. Elevance Health Inc stock trades on NYSE under the ticker symbol ELV.

  3. Elevance Health Inc's market capitalization is $89.47B as of September 19, 2026 at 1:30 AM IST.

  4. Elevance Health Inc's price-to-earnings (P/E) ratio is 18.45 as of September 18, 2026.

  5. Elevance Health Inc's price-to-book (P/B) ratio is 2.01 as of September 18, 2026.

  6. Yes, Elevance Health Inc pays a dividend, with a current dividend yield of 1.64%.

  7. Yes, You can buy Elevance Health Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Elevance Health Inc shares in three steps: 1. Search Elevance Health Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Elevance Health Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Elevance Health Inc (ELV) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0243 shares at the current price of $410.94.

Loading...